Literature DB >> 9085168

Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells.

Y Hinoda1, T Saito, H Takahashi, F Itoh, M Adachi, K Imai.   

Abstract

Nonspecific cross-reacting antigen (NCA), a member of the carcinoembryonic antigen (CEA) family, shows increased expression levels in colorectal cancer tissues. To elucidate the mechanism, we observed the effect of interferon (IFN)-gamma on the expression level of NCA mRNA in colon cancer cell lines by quantitative reverse transcriptase-polymerase chain reaction assay. IFN-gamma induced NCA mRNA in three of four cell lines tested. The effect of anti-fibronectin receptor (FnR) antibody on the expression of NCA mRNA was then examined in the same manner. Colo201 and DLD-1 cells showed an increased expression level of NCA mRNA after stimulation with the antibody. On flow cytometry, FnR was expressed in only two, Colo201 and DLD-1, of the five cell lines tested. These findings indicate that IFN-gamma and anti-FnR antibody induce NCA mRNA in cultured colon cancer cell lines, suggesting that inflammatory response and cell-to-extracellular matrix interaction may be related to the increased expression of NCA mRNA in colorectal cancers in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085168     DOI: 10.1007/bf02936368

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  12 in total

1.  Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen.

Authors:  S von Kleist; G Chavanel; P Burtin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

2.  Correlated expression of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in malignant and nonmalignant tissues of the colon.

Authors:  Y Hinoda; H Takahashi; T Higashide; T Nakano; Y Arimura; M Yoshimoto; M Tsujisaki; K Imai; A Yachi
Journal:  Jpn J Clin Oncol       Date:  1991-04       Impact factor: 3.019

3.  Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins.

Authors:  L M Sollid; D Kvale; P Brandtzaeg; G Markussen; E Thorsby
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

4.  IFN-gamma induces the expression of the genes for MHC class II I-A beta and tumor necrosis factor through a protein kinase C-independent pathway.

Authors:  A Celada; R A Maki
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

5.  Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines.

Authors:  N W Toribara; T L Sack; J R Gum; S B Ho; J E Shively; J K Willson; Y S Kim
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

6.  Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

Authors:  T Takahashi; Y Makiguchi; Y Hinoda; H Kakiuchi; N Nakagawa; K Imai; A Yachi
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

7.  Decreased expression of DCC mRNA in human colorectal cancers.

Authors:  F Itoh; Y Hinoda; M Ohe; Y Ohe; T Ban; T Endo; K Imai; A Yachi
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

8.  Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.

Authors:  M Yoshimoto; F Itoh; H Yamamoto; Y Hinoda; K Imai; A Yachi
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

9.  Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.

Authors:  H Yamamoto; F Itoh; Y Hinoda; A Senota; M Yoshimoto; H Nakamura; K Imai; A Yachi
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

10.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  4 in total

1.  Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.

Authors:  Yuan Tian; Zhihao Yao; Richard B S Roden; Hui Zhang
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

2.  Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility.

Authors:  K Murata; M Kameyama; F Fukui; H Ohigashi; M Hiratsuka; Y Sasaki; T Kabuto; M Mukai; T Mammoto; H Akedo; O Ishikawa; S Imaoka
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Authors:  Rosalyn D Blumenthal; Evelyn Leon; Hans J Hansen; David M Goldenberg
Journal:  BMC Cancer       Date:  2007-01-03       Impact factor: 4.430

4.  CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.

Authors:  Ok-Jun Lee; Seung-Myoung Son; Kwon Pyo Hong; Yong-Moon Lee; Min-Young Kim; Jae-Woon Choi; Sang-Jeon Lee; Young-Jin Song; Hak Soon Kim; Wun-Jae Kim; See-Ok Shin; Hyung Geun Song
Journal:  Virchows Arch       Date:  2014-11-27       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.